Diagnostic Medical Systems (XPAR:ALDMS) Piotroski F-Score: 7 (As of Jun. 26, 2026) — 75% Above Median


XPAR:ALDMS Diagnostic Medical Systems XPAR:ALDMS
68 GF Score
Price €1.25
GF Value €1.14
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Diagnostic Medical Systems Piotroski F-Score?

Diagnostic Medical Systems XPAR:ALDMS -1.57% 68 Piotroski F-Score is 7 as of Jun. 26, 2026, which is 75% above its 10-year median of 4.00. GuruFocus rates XPAR:ALDMS with a GF Score™ of 68/100 and a GF Value™ of €1.14 (Fairly Valued). The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Diagnostic Medical Systems ranks better than 92.42% on this metric.

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Diagnostic Medical Systems has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Diagnostic Medical Systems's Piotroski F-Score or its related term are showing as below:

XPAR:ALDMS' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 7
Current: 7

During the past 13 years, the highest Piotroski F-Score of Diagnostic Medical Systems was 7. The lowest was 2. And the median was 4.

Diagnostic Medical Systems  (XPAR:ALDMS) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Diagnostic Medical Systems Piotroski F-Score Related Terms


Diagnostic Medical Systems Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Diagnostic Medical Systems's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnostic Medical Systems Piotroski F-Score Chart

Diagnostic Medical Systems Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 5.00 4.00 6.00 7.00

Diagnostic Medical Systems Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Dec25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 4.00 0.00 6.00 7.00

XPAR:ALDMS vs ABT, SYK, MDT: Piotroski F-Score Comparison

For the Medical Devices subindustry, Diagnostic Medical Systems's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnostic Medical Systems Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Diagnostic Medical Systems's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Diagnostic Medical Systems's Piotroski F-Score falls into.


XPAR:ALDMS
68GF Score
Diagnostic Medical Systems XPAR:ALDMS
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Net Income was €-0.17 Mil.
Cash Flow from Operations was €0.50 Mil.
Revenue was €49.97 Mil.
Gross Profit was €20.44 Mil.
Average Total Assets from the begining of this year (Dec24)
to the end of this year (Dec25) was (53.949 + 62.517) / 2 = €58.233 Mil.
Total Assets at the begining of this year (Dec24) was €53.95 Mil.
Long-Term Debt & Capital Lease Obligation was €9.78 Mil.
Total Current Assets was €37.96 Mil.
Total Current Liabilities was €27.62 Mil.
Net Income was €-2.88 Mil.

Revenue was €46.07 Mil.
Gross Profit was €18.39 Mil.
Average Total Assets from the begining of last year (Dec23)
to the end of last year (Dec24) was (51.138 + 53.949) / 2 = €52.5435 Mil.
Total Assets at the begining of last year (Dec23) was €51.14 Mil.
Long-Term Debt & Capital Lease Obligation was €11.52 Mil.
Total Current Assets was €30.30 Mil.
Total Current Liabilities was €23.50 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Diagnostic Medical Systems's current Net Income (TTM) was -0.17. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Diagnostic Medical Systems's current Cash Flow from Operations (TTM) was 0.50. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec24)
=-0.167/53.949
=-0.00309552

ROA (Last Year)=Net Income/Total Assets (Dec23)
=-2.88/51.138
=-0.0563182

Diagnostic Medical Systems's return on assets of this year was -0.00309552. Diagnostic Medical Systems's return on assets of last year was -0.0563182. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Diagnostic Medical Systems's current Net Income (TTM) was -0.17. Diagnostic Medical Systems's current Cash Flow from Operations (TTM) was 0.50. ==> 0.50 > -0.17 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec24 to Dec25
=9.781/58.233
=0.16796318

Gearing (Last Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=11.522/52.5435
=0.21928497

Diagnostic Medical Systems's gearing of this year was 0.16796318. Diagnostic Medical Systems's gearing of last year was 0.21928497. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec25)=Total Current Assets/Total Current Liabilities
=37.956/27.623
=1.37407233

Current Ratio (Last Year: Dec24)=Total Current Assets/Total Current Liabilities
=30.299/23.497
=1.28948376

Diagnostic Medical Systems's current ratio of this year was 1.37407233. Diagnostic Medical Systems's current ratio of last year was 1.28948376. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Diagnostic Medical Systems's number of shares in issue this year was 24.723. Diagnostic Medical Systems's number of shares in issue last year was 22.772. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=20.441/49.974
=0.4090327

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=18.392/46.069
=0.39922725

Diagnostic Medical Systems's gross margin of this year was 0.4090327. Diagnostic Medical Systems's gross margin of last year was 0.39922725. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec24)
=49.974/53.949
=0.9263193

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec23)
=46.069/51.138
=0.90087606

Diagnostic Medical Systems's asset turnover of this year was 0.9263193. Diagnostic Medical Systems's asset turnover of last year was 0.90087606. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+1+1+1+1+0+1+1
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Diagnostic Medical Systems has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 7 mean?
Diagnostic Medical Systems (XPAR:ALDMS) has a Piotroski F-Score of 7 as of Jun. 26, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Diagnostic Medical Systems and its competitors. This is 75% above median its historical median of 4.00. Over the past decade, Diagnostic Medical Systems' Piotroski F-Score has ranged from 2.00 to 7.00. According to the industry distribution chart, Diagnostic Medical Systems ranks #61 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 7.6%.
Is Diagnostic Medical Systems' Piotroski F-Score too high?
Diagnostic Medical Systems' current Piotroski F-Score of 7 is 75% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 7.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Diagnostic Medical Systems' value of 7 is 40% above this industry median. Based on the distribution chart, Diagnostic Medical Systems ranks #61 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Diagnostic Medical Systems has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Diagnostic Medical Systems' Piotroski F-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Diagnostic Medical Systems ranks #61 out of 805 companies for Piotroski F-Score. This places Diagnostic Medical Systems in the top 8% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Diagnostic Medical Systems' value of 7 is 40% above this benchmark. Historically, Diagnostic Medical Systems' own Piotroski F-Score has ranged from 2.00 to 7.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, Diagnostic Medical Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Diagnostic Medical Systems's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Diagnostic Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diagnostic Medical Systems's current Piotroski F-Score is 7, which is 75% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostic Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Diagnostic Medical Systems (XPAR:ALDMS) is currently considered Fairly Valued. The stock's GF Value™ is €1.14, compared to a current price of €1.25 — trading 9.6% above its estimated fair value. The current Piotroski F-Score is 7, which is 75% above median its 10-year median of 4.00 and 40% above the Medical Devices & Instruments industry median of 5.00. Diagnostic Medical Systems' overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Diagnostic Medical Systems (XPAR:ALDMS), the current Piotroski F-Score is 7 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diagnostic Medical Systems (XPAR:ALDMS) Overvalued in 2026?

Based on GuruFocus' analysis, Diagnostic Medical Systems stock appears to be overvalued. The current stock price of €1.25 is trading 9.6% above its estimated GF Value™ of €1.14. GuruFocus considers Diagnostic Medical Systems to be Fairly Valued.

Key valuation signals for XPAR:ALDMS:

  • Piotroski F-Score: 7 (75% above median its 10-year median of 4.00)
  • GF Value™: €1.14 vs. price of €1.25 (9.6% above fair value)
  • GF Score™: 68/100 with 4 warning signs
  • Industry Position: 40% above the Medical Devices & Instruments median (#61 of 805)

No single metric tells the full story. See the XPAR:ALDMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Diagnostic Medical Systems Business Description

Other Exchanges 0RIA:UKDMS1:Germany
Address 9 Avenue du Canal Philippe, Gallargues le Montueux, FRA, FR-30660
Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.
68GF Score

Get the complete analysis for XPAR:ALDMS

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.25
Price
€1.14
GF Value